Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Bayer claims a series of ECE inhibitors for use in cardiovascular disorders

May 6, 2003

Locus and Speedel collaborate to design novel renin inhibitors

May 5, 2003

Additional analysis of TP-10 phase II data reveals benefit in males

May 2, 2003

Patent broadens coverage of Avant's CETP vaccine technology

May 2, 2003

Novel calcium channel blockers and their use in hypertension, angina, etc.

April 30, 2003

The effects of sPLA2 inhibitor on the survival rate of patients with severe sepsis

April 28, 2003

Drotrecogin alfa (activated) reduces mortality and organ failure in severe sepsis

April 28, 2003

Cypher stent approved by FDA

April 28, 2003

Liprostin trial planned in critical limb ischemia and intermittent claudication

April 25, 2003

Novartis claims novel ACE/NEP inhibitors with utility in hypertension therapy

April 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...